BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 34284037)

  • 1. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
    Ge J; Pletcher MJ; Lai JC;
    Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.
    Ge J; Pletcher MJ; Lai JC;
    medRxiv; 2021 Jun; ():. PubMed ID: 34127981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough SARS-CoV-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: A National COVID Cohort Collaborative study.
    Ge J; Digitale JC; Pletcher MJ; Lai JC;
    Hepatology; 2023 Mar; 77(3):834-850. PubMed ID: 36799617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakthrough SARS-CoV-2 Infection Outcomes in Vaccinated Patients with Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
    Ge J; Digitale JC; Pletcher MJ; Lai JC;
    medRxiv; 2022 Jul; ():. PubMed ID: 35821984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
    Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
    J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cirrhosis and Severe Acute Respiratory Syndrome Coronavirus 2 Infection in US Veterans: Risk of Infection, Hospitalization, Ventilation, and Mortality.
    Ioannou GN; Liang PS; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Fan VS; Dominitz JA
    Hepatology; 2021 Jul; 74(1):322-335. PubMed ID: 33219546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
    Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
    Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.
    Bennett TD; Moffitt RA; Hajagos JG; Amor B; Anand A; Bissell MM; Bradwell KR; Bremer C; Byrd JB; Denham A; DeWitt PE; Gabriel D; Garibaldi BT; Girvin AT; Guinney J; Hill EL; Hong SS; Jimenez H; Kavuluru R; Kostka K; Lehmann HP; Levitt E; Mallipattu SK; Manna A; McMurry JA; Morris M; Muschelli J; Neumann AJ; Palchuk MB; Pfaff ER; Qian Z; Qureshi N; Russell S; Spratt H; Walden A; Williams AE; Wooldridge JT; Yoo YJ; Zhang XT; Zhu RL; Austin CP; Saltz JH; Gersing KR; Haendel MA; Chute CG;
    JAMA Netw Open; 2021 Jul; 4(7):e2116901. PubMed ID: 34255046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection in patients with autoimmune hepatitis.
    Marjot T; Buescher G; Sebode M; Barnes E; Barritt AS; Armstrong MJ; Baldelli L; Kennedy J; Mercer C; Ozga AK; Casar C; Schramm C; ; Moon AM; Webb GJ; Lohse AW
    J Hepatol; 2021 Jun; 74(6):1335-1343. PubMed ID: 33508378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.
    Sun J; Zheng Q; Madhira V; Olex AL; Anzalone AJ; Vinson A; Singh JA; French E; Abraham AG; Mathew J; Safdar N; Agarwal G; Fitzgerald KC; Singh N; Topaloglu U; Chute CG; Mannon RB; Kirk GD; Patel RC;
    JAMA Intern Med; 2022 Feb; 182(2):153-162. PubMed ID: 34962505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome.
    Alur-Gupta S; Boland MR; Dokras A;
    Fertil Steril; 2023 May; 119(5):847-857. PubMed ID: 36693555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic.
    Kim D; Bonham CA; Konyn P; Cholankeril G; Ahmed A
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2664-2666.e2. PubMed ID: 34256143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study.
    Riou M; Marcot C; Canuet M; Renaud-Picard B; Chatron E; Porzio M; Dégot T; Hirschi S; Metz-Favre C; Kassegne L; Ederle C; Khayath N; Labani A; Leyendecker P; De Blay F; Kessler R;
    Respir Med Res; 2021 May; 79():100801. PubMed ID: 33259989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
    Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
    J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.
    Satapathy SK; Roth NC; Kvasnovsky C; Hirsch JS; Trindade AJ; Molmenti E; Barish M; Hirschwerk D; Da BL; Bernstein D;
    Hepatol Int; 2021 Jun; 15(3):766-779. PubMed ID: 33826042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    Thuluvath PJ; Robarts P; Chauhan M
    J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study.
    Kim D; Adeniji N; Latt N; Kumar S; Bloom PP; Aby ES; Perumalswami P; Roytman M; Li M; Vogel AS; Catana AM; Wegermann K; Carr RM; Aloman C; Chen VL; Rabiee A; Sadowski B; Nguyen V; Dunn W; Chavin KD; Zhou K; Lizaola-Mayo B; Moghe A; Debes J; Lee TH; Branch AD; Viveiros K; Chan W; Chascsa DM; Kwo P; Dhanasekaran R
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1469-1479.e19. PubMed ID: 32950749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.
    Mendizabal M; Ridruejo E; Piñero F; Anders M; Padilla M; Toro LG; Torre A; Montes P; Urzúa A; Gonzalez Ballerga E; Silveyra MD; Michelato D; Díaz J; Peralta M; Pages J; García SR; Gutierrez Lozano I; Macias Y; Cocozzella D; Chavez-Tapia N; Tagle M; Dominguez A; Varón A; Vera Pozo E; Higuera-de la Tijera F; Bustios C; Conte D; Escajadillo N; Gómez AJ; Tenorio L; Castillo Barradas M; Schinoni MI; Bessone F; Contreras F; Nazal L; Sanchez A; García M; Brutti J; Cabrera MC; Miranda-Zazueta G; Rojas G; Cattaneo M; Castro-Narro G; Rubinstein F; Silva MO
    Ann Hepatol; 2021; 25():100350. PubMed ID: 33864948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.